D
LYRA

Diversified’s LYRA THERAPEUTICS INC LYRA Stock Holding History

Diversified’s Portfolio LYRA Stock Details LYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$3.07K Buy
+239
New +$3.51K ﹤0.01% 229

Other funds holding LYRA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Diversified's LYRA Position: Q3 2024 in Review

Diversified opened a new position in LYRA THERAPEUTICS INC (LYRA) in Q3 2024: 239 shares worth $3.07K. The stake represents ﹤0.01% of the portfolio and ranks #229 among its holdings.

62 funds tracked by Wall St. Rank hold LYRA as of Q3 2024.

  • Diversified held 239 shares of LYRA THERAPEUTICS INC worth $3.07K as of Q3 2024.
  • LYRA THERAPEUTICS INC was a new Diversified position in Q3 2024.
  • LYRA THERAPEUTICS INC made up ﹤0.01% of Diversified's portfolio in Q3 2024, its #229 holding.
  • 62 funds tracked by Wall St. Rank held LYRA THERAPEUTICS INC as of Q3 2024.

Based on Diversified's 13F filing for Q3 2024, filed 13 Nov 2024.